Session Datesort descending
Optimizing the Use and Safety of ADCs in Metastatic Breast Cancer: Indications, Toxicity Profiles, and Proactive Management 01/06/2026 - 8:00am to 9:00am EST
Institutional Strategies to Prevent and Manage Toxicities from ADCs: Dato-DXd, Sacituzumab Govitecan, T-DXd, and TDM-1 01/22/2026 - 12:00pm to 1:00pm EST
Baseline Findings From a Multidisciplinary PI/QI Assessment of Care Coordination for Breast Cancer Patients Receiving ADCs 02/05/2026 - 12:00pm to 1:00pm EST
Prioritizing System-Level Improvements in ADC Care: From Baseline Gaps to Targeted Interventions 02/19/2026 - 12:00pm to 1:00pm EST